Thomas Sandgaard
Net Worth
Last updated:
What is Thomas Sandgaard net worth?
The estimated net worth of Mr. Thomas Sandgaard is at least $48,045,162 as of 14 Nov 2024. He owns shares worth $23,219,823 as insider, has earned $14,305,389 from insider trading and has received compensation worth at least $10,519,950 in Zynex, Inc..
What is the salary of Thomas Sandgaard?
Mr. Thomas Sandgaard salary is $500,950 per year as Founder, Pres, Chief Executive Officer & Chairman in Zynex, Inc..
How old is Thomas Sandgaard?
Mr. Thomas Sandgaard is 66 years old, born in 1959.
What stocks does Thomas Sandgaard currently own?
As insider, Mr. Thomas Sandgaard owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Zynex, Inc. (ZYXI) | Founder, Pres, Chief Executive Officer & Chairman | 14,603,662 | $1.59 | $23,219,823 |
What does Zynex, Inc. do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Thomas Sandgaard insider trading
Zynex, Inc.
Mr. Thomas Sandgaard has made 52 insider trades between 2004-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,000 units of ZYXI stock worth $16,180 on 14 Nov 2024.
The largest trade he's ever made was exercising 1,250,000 units of ZYXI stock on 14 Jul 2020. As of 14 Nov 2024 he still owns at least 14,603,662 units of ZYXI stock.
Zynex key executives
Zynex, Inc. executives and other stock owners filed with the SEC:
- Mr. Daniel J. Moorhead (53) Chief Financial Officer
- Mr. Thomas Sandgaard (66) Founder, Pres, Chief Executive Officer & Chairman
- Ms. Anna Lucsok (39) Chief Operating Officer